Clinical trial
Treating Schizophrenia by Correcting Abnormal Brain Development
NCT00179465
Study timeline
Study start (actual)2003-11-01Date precision: month
Registry last updated2025-01-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophreniaverified · MONDO: schizophrenia
Interventions
TiagabineDRUG · verified · RxNorm: tiagabine
PlaceboDRUG
Sponsors & collaborators
Beth Israel Deaconess Medical Centerlead sponsor
Dartmouth-Hitchcock Medical Centercollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00179465 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.